Web Stats Provided By Google Analytics

Tuesday, January 21, 2014

ViiV Healthcare's new HIV medicine Tivicaya (dolutegravir) is approved in Europe

... who participated in it, and we aim to move forward together with them based on an absolute commitment to the HIV/AIDS global response," said Dr Today's approval of Tivicay is the European regulatory authorisation to market the medicine in each ...

http://ift.tt/1fVsUft

No comments:

Post a Comment